Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels

NCT03771040 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

347

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Masitinib
DRUG: Placebo

Sponsor

AB Science